Find your next paid study

Reema A. PatelNCT05493215

Repurposing a Combination Antiretroviral Drug Therapy to Target Retrotransposons and Treat Early Alzheimer's Disease

The goal of this clinical trial is to determine the safety, tolerability, drug levels and biological effects of two doses of emtricitabine (FTC) and tenofovir …

Alzheimer's Disease

Brigham and Women's HospitalNCT07795307

Phase 3

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Nalbuphine Extended-Release Tablets for the Treatment of Chronic Cough in Participants With Idiopathic Pulmonary Fibrosis

The primary purpose is to evaluate the safety and efficacy of NAL ER for the treatment of chronic cough in participants with Idiopathic Pulmonary Fibrosis (IPF…

Idiopathic Pulmonary Fibrosis

Trevi TherapeuticsNCT07671911

~$10 – $8,750

Intractable PainPalliative Care

A Phase I Study of the Intrathecal Administration of Resiniferatoxin for Treating Severe Refractory Pain Associated With Advanced Cancer

This study will examine the safety of giving the experimental drug, resiniferatoxin (RTX), to treat severe pain in patients with advanced cancer. RTX is a chem…

National Institute of Dental and Craniofacial Research (NIDCR)NCT00804154

~$10 – $5,625

Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach

Background: Primary sclerosing cholangitis is a rare chronic liver disease. It affects the bile ducts of the liver. It can result in bile duct infections, ci…

Primary Sclerosing Cholangitis

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT04685200

~$10 – $675

Phase 2

Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma

To learn if obinutuzumab in combination with CC-99282 can help to control previously untreated, high tumor burden FL

Follicular LymphomaTumor

M.D. Anderson Cancer CenterNCT06108232

Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia, RefractoryPediatric ALL

A Phase I Study Evaluating Allogeneic Memory T Cells Engineered to Express Chimeric Antigen Receptors Specific for CD19 for the Treatment of Pediatric and Young Adult Patients ≤ 21 Years of Age With Relapsed or Refractory CD19-Positive Leukemia

This is a Phase I clinical study evaluating the safety and maximum tolerated dose of a novel CAR T-cell product: allogeneic memory (CD45RA- negative) T-cells e…

St. Jude Children's Research HospitalNCT04881240

Phase 3

Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults With Cancer

This phase III trial compares the effect of giving triptorelin vs no triptorelin in preventing ovarian damage in adolescents and young adults (AYAs) with cance…

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm

Children's Oncology GroupNCT06513962

Observational

Activities to Change Your Mood: A Test of the Acceptability and Initial Efficacy in Clinical Samples and Healthy Controls

This is a study investigating how brief online activities can influence mood and attitudes.

Schizophrenia Disorders

University of Alabama at BirminghamNCT06911723

Multiple System AtrophyParkinsons Disease

A Phase I Study of the Feasibility and Safety of SuraL nervE Tissue Grafting to the Substantia nigrA in Patients With Synucleinopathies (LEAP)

This phase I double-blind study focuses on the safety and feasibility of implanting autologous peripheral nerve tissue (PNT) into the substantia nigra area of …

Craig van Horne, MD, PhDNCT06683365

Phase 3

A Phase III, Multicenter, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Induction Therapy With RO7790121 in Patients With Moderately to Severely Active Crohn's Disease

This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (also known as R…

Moderately to Severely Active Crohns Disease